MM3122 is a promising lead candidate small molecule drug for the treatment and prevention of infections caused by SARS-CoV-2 and other coronaviruses.
Domain | mm3122inhibitor.com |
---|---|
Homepage URL | https://mm3122inhibitor.com/systematic-report-on-efficiency-along-with-security-regarding-substance-danshen-treatment-joined-with-american-medicine-throughout-treatment-of-general-dementia/ |
Keywords | mm3122 inhibitor galectin modulator pulmonary infection |
Sprache | englisch |